Samrat Pharmachem Q4 Results

  • BSE: 530125
  • NSE: -
  • ISIN: INE103E01016
  • Sector: Biotechnology & Drugs
BSE
45312.05 (2.73%)
Volume3.69 K
Updated: Mon 25 Nov, 2024 | 15:26:49
NSE
This stock is not traded on NSE
Today: 440.00
462.00
52-Wk: 320.00
646.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Samrat Pharmachem Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 82.6883.99-%69.03-%
    Selling/ General/ Admin Expenses Total 0.661.20-%0.58-%
    Depreciation/ Amortization 0.160.16-%0.16-%
    Other Operating Expenses Total 1.74--%1.70-%
    Total Operating Expense 81.4980.73-%69.83-%
    Operating Income 1.203.26-%-0.80-%
    Net Income Before Taxes 1.392.77-%-0.79-%
    Net Income 1.402.10-%-0.74-%
    Diluted Normalized EPS 4.526.78-%-2.41-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts